$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Whole-brain imaging at single-cell resolution is an important challenge in neuroscience. Cellular-resolution brain images allow for detailed analysis and system-level mapping of brain circuitry and how that circuitry is disrupted by genetic or environmental risk factors for neuropsychiatric disorders, cellular behavior in developing embryos, as well as neural circuits in the adult brain1,2,3. There are multiple histological methods that allow for high-resolution images of the reconstructed 3D brain; however, these techniques require expensive, specialized equipment, may not be compatible with immunolabeling, and the two-dimensional (2D) nature of some methods may lead to tissue damage and shearing during sectioning4,5.
Recent advancements have provided an alternative approach for imaging entire brains that does not require tissue sectioning; they involve using tissue clearing to make brains transparent. Transparency is achieved in most tissue clearing methods by both removing lipids, as they are a major source of light scattering, and matching the refractive index (RI) of the object with the RI of the sample immersion solution during imaging. Light can then pass through the boundary between materials without being scattered6,7,8,9.
Tissue clearing methods, such as iDISCO+, are often combined with rapid 3D imaging using single-photon excitation microscopy, such as LSFM6,7,10. Within transparent tissues labeled with a fluorophore, light-sheet fluorescence microscopy images sections by excitation with a thin plane of light11. The main advantage of LSFM is that a single optical section is illuminated at a time, with all the fluorescence from the molecules within that section being excited, which minimizes photobleaching. Moreover, imaging an entire optical slice enables camera-based detection of that excited slice, increasing speed relative to point scanning12. LSFM nondestructively produces well-registered optical sections that are suitable for 3D reconstruction.
While the iDISCO+ method allows for inexpensive tissue clearing within ~3 weeks, dehydration steps within the protocol may lead to tissue shrinkage and potential alteration of the sample morphology, thus affecting volumetric measurements6,10. Adding a secondary imaging method, such as MRI, to be used prior to the tissue clearing procedure can measure the degree of tissue clearing-induced shrinkage across the sample. During the dehydration steps, differences in mechanical properties between gray and white matter may lead to nonuniform brain matter deformations, resulting in dissimilar tissue clearing-induced volume deformations between wild-type and mutant samples and may confound interpretations of volumetric differences in these samples10,13. MRI is performed by first perfusing the animal with a contrast agent (e.g., gadolinium), followed by incubating the extracted tissue of interest in an immersion solution (e.g., fomblin) before imaging14. MRI is compatible with tissue clearing and performing LSFM on the same sample.
LSFM is often used to create large-scale microscopy images for qualitative visualization of the brain tissue of interest rather than quantitative evaluation of brain structure (Figure 1). Without quantitative evaluation, it is difficult to demonstrate structural differences resulting from genetic or environmental insults. As tissue-clearing and imaging technologies improve, along with decreased costs of storage and computing power, quantifying cell type localizations within the tissue of interest is becoming more accessible, allowing more researchers to include these data in their studies.
With over 100 million cells in the mouse brain15 and whole-brain imaging sessions that can generate terabytes of data, there is increased demand for advanced image analysis tools that allow accurate quantification of features within the images, such as cells. A host of segmentation methods exist for tissue-cleared images that apply thresholding for nuclear staining intensity and filter objects with predefined shapes, sizes, or densities10,16,17,18. However, inaccurate interpretations of results can arise from variations in parameters such as cell size, image contrast, and labeling intensity. This paper describes our established protocol to quantify cell nuclei in the mouse brain. First, we detail steps for tissue collection of the P4 mouse brain, followed by a tissue clearing and immunolabeling protocol optimized from the publicly available iDISCO+ method10. Second, we describe image acquisition using MRI and light-sheet microscopy, including the parameters used for capturing images. Finally, we describe and demonstrate NuMorph19, a set of image analysis tools our group has developed that allows cell-type specific quantification after tissue clearing, immunolabeling with nuclear markers, and light-sheet imaging of annotated regions.